Racura Oncology Ltd (ASX:RAC)
Australia · Delayed Price · Currency is AUD 2.150
-0.100 (-4.44%)
Aug 28, 2026, 4:10 PM AEST
Racura Oncology Market Cap
Racura Oncology has a market cap or net worth of 441.16 million as of August 28, 2026. Its market cap has increased by 103.13% in one year.
Market Cap
441.16M
Enterprise Value
406.87M
Revenue
2.81M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.15
ChartMarket Cap Chart
Since July 13, 2016, Racura Oncology's market cap has increased from 12.64M to 441.16M, an increase of 3,390.93%. That is a compound annual growth rate of 42.00%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 421.55M | -14.60% |
| Dec 31, 2025 | 493.64M | 110.49% |
| Dec 31, 2024 | 234.51M | 70.76% |
| Dec 29, 2023 | 137.34M | -57.61% |
| Dec 30, 2022 | 324.00M | -43.55% |
| Dec 31, 2021 | 574.00M | 153.36% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Clarity Pharmaceuticals | 932.70M |
| Clinuvel Pharmaceuticals | 530.50M |
| Tetratherix | 357.46M |
| Starpharma Holdings | 348.25M |
| BLS Pharmaceuticals | 211.58M |
| Orthocell | 211.00M |
| Nyrada | 192.73M |
| Dimerix | 189.12M |